human
herp
famili
virus
hhv
consist
eight
separ
virus
potenti
caus
human
diseas
preval
gener
popul
respect
mostli
transmit
nonsexu
contact
frequent
associ
oral
mucos
lesion
mostli
transmit
sexual
contact
commonli
infect
urogenit
mucosa
shortli
primari
infect
viru
found
dormant
state
sensori
neuron
reactiv
may
occur
later
time
immunocompromis
patient
increas
risk
reactiv
subsequ
dissemin
diseas
hsv
reactiv
posttranspl
patient
caus
pneumonia
hepat
enceph
dissemin
diseas
oral
acyclovir
shown
effect
prophylact
treatment
agent
varicella
zoster
viru
vzv
respons
chickenpox
shingl
healthi
immunocompet
popul
howev
may
caus
signific
lifethreaten
diseas
immunocompromis
popul
posttranspl
patient
primari
infect
chickenpox
reactiv
shingl
healthi
patient
intact
immun
system
manifest
vesicular
rash
dermatom
pattern
shortli
primari
infect
vzv
remain
dormant
neuron
dorsal
root
ganglia
howev
reactiv
posttranspl
patient
may
manifest
cutan
infect
enceph
myeliti
pneumonia
mani
studi
document
efficaci
acyclovir
ganciclovir
prophylaxi
vzv
vaccin
avail
patient
close
contact
shown
effect
prevent
diseas
epsteinbarr
viru
ebv
caus
viru
associ
infecti
mononucleosi
seriou
rare
burkitt
lymphoma
nasopharyng
carcinoma
posttranspl
lymphoprolif
disord
ptld
gener
popul
found
seroposit
ebv
patient
gener
demonstr
flulik
symptom
signific
symptom
may
occur
includ
enceph
optic
neuriti
hepatosplenomegali
increas
risk
splenic
ruptur
like
vzv
ebv
gener
transmit
respiratori
secret
saliva
shortli
primari
infect
ebv
found
dormant
state
b
cell
immun
system
vaccin
current
exist
ebv
although
studi
shown
effect
antivir
medic
treatment
cytomegaloviru
cmv
common
infect
prolong
latenc
period
estim
seroposit
rate
rang
young
adult
elderli
popul
infect
occur
asymptomat
healthi
popul
immunocompromis
patient
risk
dissemin
diseas
particular
postlung
transplant
patient
risk
cmv
pneumon
common
caus
bronchiol
obliteran
syndrom
valganciclovir
shown
effect
prophylact
measur
highrisk
patient
common
infect
occur
popul
caus
roseola
infantum
manifest
high
fever
viral
exanthem
rash
primari
infect
remain
dormant
lymphocyt
reactiv
immunocompromis
patient
may
lead
neurolog
symptom
gastroenter
pneumon
hepat
myelosuppress
vaccin
current
exist
antivir
agent
effect
treatment
gain
attent
opportunist
diseas
aid
patient
refer
kaposi
sarcoma
addit
caus
agent
primari
effus
lymphoma
multicentr
castleman
diseas
immunocompromis
patient
american
seroposit
subsaharan
popul
infect
treatment
diseas
appear
reduct
degre
immunosuppress
chemotherapi
radiat
therapi
also
resect
local
tumor
treatment
coinfect
respiratori
syncyti
viru
rsv
parainfluenza
part
paramyxoviru
famili
frequent
caus
upper
lower
respiratori
tract
infect
children
peak
season
appear
occur
winter
similar
influenza
immunocompromis
patient
posttranspl
lymphopen
patient
like
progress
infect
lower
respiratori
tract
significantli
higher
mortal
rate
paramyxovirus
associ
posttranspl
complic
includ
postvir
oblit
bronchiol
caus
chronic
reject
vaccin
avail
rsv
prophylaxi
effect
manag
immunoglobulin
monoclon
antibodi
treatment
center
use
ribavirin
rsv
antibodi
support
measur
comparison
proven
prevent
treatment
measur
parainfluenza
perhap
one
viru
gain
global
notorieti
histori
global
epidem
influenza
viru
despit
widespread
vaccin
potenti
antigen
shift
drift
exist
situat
could
contribut
worldwid
pandem
influenza
b
rna
virus
caus
upper
lower
respiratori
tract
diseas
like
rsv
progress
lower
respiratori
tract
diseas
preval
immunocompromis
patient
diseas
peak
winter
neuraminidas
inhibitor
oseltamivir
zanamivir
effect
treatment
especi
begun
earli
viral
cours
treatment
augment
amantadin
rimantadin
vaccin
avail
may
cover
strain
viru
bloodborn
virus
major
concern
hospit
patient
healthcar
provid
viru
transmiss
infect
host
percutan
mucos
penetr
report
human
immunodefici
viru
hiv
hepat
c
hepat
b
order
calcul
risk
transmiss
percutan
mucou
membran
injuri
sever
factor
must
consid
includ
method
transmiss
needl
penetr
versu
blood
splash
mucou
membran
needl
type
hollowbor
needl
iv
needl
versu
solidbor
needl
sutur
needl
needl
gaug
penetr
needl
patient
healthcar
worker
presenc
blood
needl
access
needl
patient
bloodstream
whether
needl
pass
glove
barrier
prior
enter
skin
person
protect
equip
situat
awar
remain
mainstay
prevent
effect
protect
method
minim
risk
transmiss
bloodborn
diseas
includ
glove
doubl
glove
need
face
shield
eye
protect
sleev
reinforc
kneehigh
trauma
boot
plastic
apron
surgic
gown
avoid
blind
sutur
techniqu
hiv
rna
retroviru
produc
revers
transcriptas
allow
creation
complimentari
dna
substitut
host
cell
viru
attack
host
caus
cell
lysi
subsequ
loss
helper
cell
although
mandatori
preoper
hiv
screen
advoc
mani
ethic
concern
addit
financi
concern
barrier
screen
furthermor
consent
must
obtain
perform
test
instead
accept
practic
among
mani
practition
seem
test
either
highrisk
patient
undergo
higher
risk
procedur
regardless
patient
infect
statu
univers
precaut
standard
practic
upon
receiv
percutan
mucos
injuri
patient
unknown
hiv
statu
prophylact
treatment
begun
consent
hiv
test
obtain
patient
host
determin
asymptomat
diseas
twodrug
regimen
recommend
howev
patient
symptomat
time
exposur
threedrug
regimen
commenc
least
week
hepat
b
mainli
transmit
intraven
drug
abus
blood
transfus
sexual
contact
viral
replic
viru
occur
hepatocyt
exposur
patient
demonstr
clinic
symptom
hepat
patient
expos
spontan
clinic
resolut
antigen
posit
life
potenti
progress
chronic
hepat
cirrhosi
portal
hypertens
hepatocellular
carcinoma
state
exposur
hepat
determin
antibodi
test
presenc
core
antibodi
indic
previou
exposur
presenc
core
antigen
indic
persist
diseas
presenc
e
antigen
indic
activ
viral
replic
marker
higher
infect
surfac
antibodi
antibodi
present
signifi
previou
vaccin
hepat
b
despit
high
transmiss
hepat
b
percutan
injuri
vaccin
effect
elimin
transmiss
howev
unreact
antibodi
test
prior
vaccin
histori
risk
receiv
postexposur
prophylaxi
individu
receiv
hbv
immunoglobulin
either
booster
dose
vaccin
full
vaccin
seri
hepat
c
estim
four
million
peopl
unit
state
expos
hepat
c
transmiss
occur
intraven
drug
abus
sexual
contact
transfus
like
hepat
b
peopl
expos
demonstr
clinic
symptom
howev
unlik
hepat
b
patient
hepat
c
go
develop
chronic
diseas
chronic
diseas
progress
cirrhosi
hepatocellular
carcinoma
antibodi
test
exposur
may
yield
posit
result
year
unfortun
effect
vaccin
prophylaxi
exposur
avail
time
infecti
bacteri
organ
major
concern
consid
infect
control
measur
prevent
patientpati
transmiss
nosocomi
infect
major
sourc
morbid
mortal
includ
vancomycinresist
enterococcu
vre
methicillinresist
staphylococcu
aureu
mrsa
quinoloneresist
pseudomona
clostridium
difficil
mani
intervent
propos
erad
control
spread
nosocomi
infect
infect
control
measur
includ
proper
hand
wash
techniqu
implement
contact
precaut
activ
surveil
cultur
patient
staff
educ
effect
environment
clean
intervent
especi
combin
shown
reduc
incid
multidrugresist
organ
spread
durat
patient
isol
area
high
debat
advoc
patient
label
carrier
alway
isol
carrier
test
indic
clear
infect
result
poor
cultur
poor
sensit
remov
antibiot
select
pressur
howev
hospit
infect
control
practic
advisori
committe
hicpac
recommend
remov
isol
precaut
three
neg
cultur
least
week
apart
durat
colon
antibioticresist
organ
highli
variabl
current
unknown
mrsa
addit
nosocomi
origin
mrsa
found
commun
import
sourc
skin
soft
tissu
infect
present
outpati
set
inpati
set
lead
caus
pneumonia
surgic
site
infect
dissemin
infect
risk
factor
contract
mrsa
includ
advanc
age
prior
antibiot
use
previou
surgeri
extend
hospit
mrsa
colon
occur
asymptomat
patient
normal
skin
flora
nare
furthermor
colon
nare
shown
risk
factor
develop
surgic
site
infect
reason
mani
advoc
mrsa
screen
erad
therapi
antisept
decontamin
prior
surgeri
screen
asymptomat
patient
also
allow
effect
prevent
crosscontamin
patient
implement
isol
barrier
precaut
despit
measur
center
diseas
control
cdc
recommend
routin
activ
surveil
screen
patient
vre
nosocomialacquir
bloodstream
bacteri
infect
attribut
enterococcu
signific
percentag
vre
unlik
mrsa
vre
low
rate
asymptomat
carrier
colon
occur
like
skin
gastrointestin
tract
higher
preval
vre
found
intens
care
dialysi
oncolog
unit
common
mechan
transfer
among
patient
appear
ineffect
hand
hygien
among
healthcar
worker
contact
precaut
typic
implement
diagnosi
histori
vre
known
clostridium
difficil
consid
part
normal
intestin
flora
healthi
patient
c
difficil
overgrow
domin
intestin
flora
secondari
erad
normal
gut
flora
clinic
symptom
occur
rang
mild
diarrhea
sever
pseudomembran
coliti
toxic
megacolon
toxin
releas
bacteria
implic
caus
mucos
damag
inflamm
measur
control
spread
infect
includ
proper
hand
wash
remov
c
difficil
spore
disinfect
physic
environ
implement
contact
precaut
proper
select
antibiot
necessari
expert
recommend
contact
precaut
maintain
h
resolut
diarrhea
environment
clean
physic
exposur
infect
patient
accomplish
chlorinecontain
agent
hydrogen
peroxid
droplet
transmiss
limit
distanc
spread
host
less
due
particl
size
size
particl
sourc
controversi
world
health
organ
employ
particl
size
comparison
particl
undergo
airborn
transmiss
usual
may
remain
suspend
air
extend
amount
time
may
spread
greater
distanc
addit
smaller
infecti
particl
like
penetr
lower
respiratori
tract
larger
particl
gener
settl
upper
respiratori
tract
proper
precaut
follow
oper
room
laminar
airflow
system
hepa
filter
effect
remov
major
airborn
particl
system
ceil
wall
mount
frequent
air
chang
limit
colonyform
unit
measur
prevent
infect
transmiss
oper
room
includ
steril
surgic
gown
drape
face
mask
antisept
hand
scrub
time
open
surgic
instrument
prior
perform
procedur
tuberculosi
tb
current
eighth
lead
caus
death
worldwid
estim
world
popul
infect
highest
concentr
focus
less
develop
area
subsaharan
africa
india
southeast
central
asia
eastern
europ
micronesia
tuberculosi
spread
respiratori
droplet
individu
activ
pulmonari
diseas
healthi
patient
expos
asymptomat
local
cours
infect
may
remain
dormant
pulmonari
tissu
year
refer
latent
tuberculosi
infect
reactiv
may
occur
year
later
normal
healthi
patient
howev
reactiv
like
occur
immunocompromis
patient
patient
malign
hiv
endstag
renal
diseas
diabet
patient
immunosuppress
medic
activ
tuberculosi
character
chest
xray
find
infiltr
found
apicalposterior
segment
upper
lobe
may
includ
cavit
symptom
frequent
associ
tb
infect
includ
constitut
symptom
fever
night
sweat
cough
unintend
weight
loss
diagnosi
latent
tb
infect
made
tuberculin
skin
test
tst
interpret
test
result
base
preval
risk
patient
activ
diseas
diagnos
combin
chest
xray
find
cultur
result
acidfast
bacilli
detect
either
sputum
test
bronchoalveolar
lavag
treatment
usual
accomplish
direct
observ
therapi
dot
least
month
treatment
latent
tb
effect
treat
one
agent
danger
multidrugresist
organ
necessit
use
multipl
medic
patient
found
activ
tuberculosi
infect
kept
negativepressur
isol
room
least
air
exchang
per
hour
clinic
resolut
symptom
achiev
three
consecut
neg
result
sputum
test
healthcar
provid
wear
mask
individu
fittest
care
patient
activ
diseas
sever
acut
respiratori
syndrom
sar
sar
form
coronaviru
respons
major
pandem
affect
mani
healthcar
provid
viru
spread
respiratori
droplet
found
high
level
infect
debat
whether
viru
also
spread
greater
distanc
host
airborn
transmiss
flulik
symptom
associ
mild
acut
infect
symptom
seriou
infect
includ
reactiv
hepat
sever
acut
neurolog
syndrom
pulmonari
involv
pneumonia
acut
respiratori
distress
syndrom
ard
healthcar
provid
found
signific
risk
contract
viru
especi
care
patient
requir
oxygen
therapi
positivepressur
ventil
resuscit
recommend
healthcar
provid
care
patient
involv
strict
contact
droplet
precaut
howev
airborn
precaut
use
fit
mask
must
also
observ
perform
procedur
may
gener
aerosol
bronchoscopi
creutzfeldtjakob
diseas
cjd
famili
neurodegen
disord
becom
surgic
concern
past
coupl
decad
infecti
entiti
diseas
found
mutat
prion
proteas
resist
mean
incub
period
appear
symptom
averag
year
subacut
progress
neurolog
diseas
howev
averag
surviv
appear
symptom
month
diagnosi
made
biopsi
infect
tissu
prion
diseas
may
transmit
famili
sporad
iatrogen
spread
particular
iatrogen
form
concern
infect
control
precaut
patient
expos
prioncontamin
surgic
equip
certain
surgic
oper
ophthalmolog
neurosurg
procedur
consid
high
risk
prion
transmiss
histor
eeg
electrod
human
pituitari
hormon
cornea
transplant
dura
mater
graft
also
implic
case
report
found
transmiss
blood
transfus
infect
donor
mutat
prion
shown
less
suscept
standard
method
steril
made
specif
recommend
regard
steril
surgic
instrument
come
contact
tissu
carri
risk
high
infect
patient
suspect
confirm
prion
diseas
moreov
expert
recommend
use
dispos
surgic
instrument
situat
